Hundreds of a people who have chronic liver disease are being helped by an NHS trust's service that helps them attend vital ...

Grandmother of five Michelle Hayward was shocked when she was told she had irreversible liver damage from years of overeating ...

For patients with compensated metabolic dysfunction-associated steatohepatitis (MASH)-related cirrhosis and obesity, ...

A Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) ...

A UK clinical trial is testing whether the dietary supplement HMB can improve strength and quality of life for cirrhosis ...

Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the ...

For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma.

Though things are looking up for Akero, the stock still looks risky. Akero Therapeutics is developing efruxifermin as a ...

Akero's SYMMETRY Phase 2b study showed 50mg EFX achieved 24% cirrhosis reversal in MASH patients, with improvements in liver ...

Piper Sandler reiterated an Overweight rating and $336 price target on Madrigal Pharmaceuticals (MDGL) after Akero Therapeutics (AKRO) ...

For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and ...